BioStone Animal Health Launches Brucella suis Bp26 Antibody Test Kit
DALLAS-FORT WORTH, TX — May 3, 2022 — BioStone Animal Health is pleased to announce the launch of AsurDxTM Brucella suis Bp26 Antibody Test Kit for the detection of pig antibodies specific to Brucella suis. Brucellosis is one of the most common bacterial zoonotic diseases. This disease is caused by organisms belonging to the genus Brucella, which are facultative intracellular Gram-negative bacteria. Brucella Bp26 is one of the major outer membrane proteins of Brucella suis. Brucella Bp26 is considered an immunodominant target molecule for the detection of anti-Brucella antibodies in infected animals. Additionally, Bp26 can be used in the confirmatory differentiation of serological responses of infected animals from those of vaccinated ones. The AsurDxTM Brucella suis Bp26 Antibody Test Kit detects Brucella suis Bp26 antibodies in pig serum/plasma. The AsurDxTM Brucella suis Bp26 Antibody Test Kit provides a simple, rapid, sensitive, and cost-effective enzyme-based immunoassay (ELISA) screening method.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. BioStone strives to actively promote and participate in global animal health initiatives by making these test kits available to the international community. For more information about BioStone Animal Health, visit www.biostoneah.com